Leukemic presentation of ALK-negative anaplastic large cell lymphoma in a patient with myelodysplastic syndrome

5Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

A 50-year-old woman with a history of aplastic anemia developed cervical lymphadenopathy and atypical lymphocytosis. Atypical cells of lymph nodes were positive for CD3 and CD30 but negative for anaplastic lymphoma kinase (ALK). Bone marrow examination showed trilineage myelodysplasia. She was diagnosed with ALK-negative anaplastic large cell lymphoma (ALCL) with leukemic transformation and myelodysplastic syndrome (MDS) which presumably developed from aplastic anemia. The lymphoma was resistant to intensive chemotherapies, ultimately leading to death. Leukemic presentation of ALK-negative ALCL as an initial manifestation is extremely rare, and the progression of the disease may be influenced by MDS through alteration of immune functions. © 2012 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Tanaka, H., Ohwada, C., Hashimoto, S., Sakai, S., Takeda, Y., Abe, D., … Nakaseko, C. (2012). Leukemic presentation of ALK-negative anaplastic large cell lymphoma in a patient with myelodysplastic syndrome. Internal Medicine, 51(2), 199–203. https://doi.org/10.2169/internalmedicine.51.6146

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free